{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:48:16Z","timestamp":1792896496882,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.xphs.2023.12.017","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:14:16Z","timestamp":1703081656000},"page":"1088-1093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An Automated Capillary Electrophoresis Based Method for Drug Release Profiling of Liposomal Doxorubicin"],"prefix":"10.1016","volume":"113","author":[{"given":"Savithra","family":"Jayaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-6690","authenticated-orcid":false,"given":"Thilak","family":"Mudalige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.12.017_bib0001","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.017_bib0002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1359-6446(03)02699-0","article-title":"Targeted drug delivery systems for the intracellular delivery of macromolecular drugs","volume":"8","author":"Koning","year":"2003","journal-title":"Drug Discov Today"},{"issue":"14","key":"10.1016\/j.xphs.2023.12.017_bib0003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM197609302951406","article-title":"The carrier potential of liposomes in biology and medicine (second of two parts)","volume":"295","author":"Gregoriadis","year":"1976","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.017_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/17425247.2.3.465","article-title":"Liposomes in the treatment of inflammatory disorders","volume":"2","author":"Metselaar","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/mi.6.2.7","article-title":"Advanced drug delivery systems that target the vascular endothelium","volume":"6","author":"Ding","year":"2006","journal-title":"Mol Interv"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020288","article-title":"Liposomes: clinical applications and potential for image-guided drug delivery","volume":"23","author":"Lamichhane","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.017_bib0008","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjc.1991.476","article-title":"Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin","volume":"64","author":"Gabizon","year":"1991","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.017_bib0009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","article-title":"Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS","volume":"6","author":"James","year":"1994","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.017_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-2736(95)00159-Z","article-title":"Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery","volume":"1239","author":"Lasic","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2023.12.017_bib0012","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpharm.2012.04.011","article-title":"Designing a novel in vitro drug-release-testing method for liposomes prepared by pH-gradient method","volume":"430","author":"Nakamura","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.12.017_bib0013","series-title":"Draft Guidance on Doxorubicin Hydrochloride","year":"2022"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.017_bib0014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13346-012-0064-4","article-title":"Drug release from nanomedicines: selection of appropriate encapsulation and release methodology","volume":"2","author":"Wallace","year":"2012","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2023.12.017_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2015.08.024","article-title":"Mechanistic model and analysis of doxorubicin release from liposomal formulations","volume":"217","author":"Fugit","year":"2015","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.017_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0003-2697(90)90528-H","article-title":"Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma","volume":"188","author":"Thies","year":"1990","journal-title":"Anal Biochem"},{"issue":"12","key":"10.1016\/j.xphs.2023.12.017_bib0017","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1007\/s11095-015-1761-8","article-title":"Solid phase extraction as an innovative separation method for measuring free and entrapped drug in lipid nanoparticles","volume":"32","author":"Guillot","year":"2015","journal-title":"Pharm Res"},{"issue":"30","key":"10.1016\/j.xphs.2023.12.017_bib0018","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.jchromb.2011.10.004","article-title":"Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC","volume":"879","author":"Yamamoto","year":"2011","journal-title":"J Chromatogr B"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.017_bib0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00003088-200948040-00004","article-title":"Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years","volume":"48","author":"Peyrl","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2014.12.056","article-title":"Characterization of insulin-loaded liposome using column-switching HPLC","volume":"479","author":"Ohnishi","year":"2015","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.017_bib0021","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jps.24307","article-title":"Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes","volume":"104","author":"Csuhai","year":"2015","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.12.017_bib0022","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10611869509015959","article-title":"The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage","volume":"3","author":"Heeremans","year":"1995","journal-title":"J Drug Target"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.017_bib0023","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/mp400154a","article-title":"Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method","volume":"10","author":"Modi","year":"2013","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0024","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-4347(01)00151-7","article-title":"Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome","volume":"757","author":"Bellott","year":"2001","journal-title":"J Chromatogr B"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.017_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/bio.10.204","article-title":"In vitro and in vivo characterizations of PEGylated liposomal doxorubicin","volume":"3","author":"Jiang","year":"2011","journal-title":"Bioanalysis"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2023.12.017_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2018.07.019","article-title":"Direct quantification of unencapsulated doxorubicin in liposomal doxorubicin formulations using capillary electrophoresis","volume":"549","author":"Ansar","year":"2018","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.017_bib0027","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpba.2009.06.028","article-title":"Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence","volume":"52","author":"Kim","year":"2010","journal-title":"J Pharm Biomed Anal"},{"issue":"15","key":"10.1016\/j.xphs.2023.12.017_bib0028","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/rcm.4630","article-title":"Analysis of triglycerides in food items by desorption electrospray ionization mass spectrometry","volume":"24","author":"Gerbig","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"2","key":"10.1016\/j.xphs.2023.12.017_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chroma.2004.12.033","article-title":"Analytical study of Joule heating effects on electrokinetic transportation in capillary electrophoresis","volume":"1064","author":"Xuan","year":"2005","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.xphs.2023.12.017_bib0030","series-title":"Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"key":"10.1016\/j.xphs.2023.12.017_bib0031","first-page":"1865","article-title":"Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs","author":"Yaelle Schilt Tal Berman","year":"2021","journal-title":"BBA"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.017_bib0032","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0021-9614(75)90183-4","article-title":"Thermodynamic quantities for the dissociation of the ammonium ion and for the ionization of aqueous ammonia over a wide temperature range","volume":"7","author":"Olofsson","year":"1975","journal-title":"J Chem Thermodyn"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.017_bib0033","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12248-016-9958-2","article-title":"Development of a flow-through USP-4 apparatus drug release assay to evaluate doxorubicin liposomes","volume":"19","author":"Yuan","year":"2017","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.xphs.2023.12.017_bib0034","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.xphs.2023.12.017_bib0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/cpb.c17-00474","article-title":"Rapid analysis of DOXIL stability and drug release from DOXIL by HPLC using a glycidyl methacrylate-coated monolithic column","volume":"65","author":"Kimoto","year":"2017","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.017_bib0036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1248\/cpb.c13-00587","article-title":"Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine-cholesterol binary liposome membrane","volume":"62","author":"Kitayama","year":"2014","journal-title":"Chem Pharm Bull"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:43:57Z","timestamp":1758361437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923005440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0022354923005440"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.017","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Automated Capillary Electrophoresis Based Method for Drug Release Profiling of Liposomal Doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}